• Heterozygous carriers of deleterious germ line NBN variants are at risk of B-ALL development.

  • Protein instability is the main mechanism for loss-of-function variants in the NBN gene.

Abstract

Biallelic mutation in the DNA-damage repair gene NBN is the genetic cause of Nijmegen breakage syndrome, which is associated with predisposition to lymphoid malignancies. Heterozygous carriers of germ line NBN variants may also be at risk for leukemia development, although this is much less characterized. By sequencing 4325 pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL), we systematically examined the frequency of germ line NBN variants and identified 25 unique, putatively damaging NBN coding variants in 50 patients. Compared with the frequency of NBN variants in gnomAD noncancer controls (189 unique, putatively damaging NBN coding variants in 472 of 118 479 individuals), we found significant overrepresentation in pediatric B-ALL (P = .004; odds ratio, 1.8). Most B-ALL–risk variants were missense and cluster within the NBN N-terminal domains. Using 2 functional assays, we verified 14 of 25 variants with severe loss-of-function phenotypes and thus classified these as nonfunctional or partially functional. Finally, we found that germ line NBN variant carriers, all of whom were identified as heterozygous genotypes, showed similar survival outcomes relative to those with wild type status. Taken together, our findings provide novel insights into the genetic predisposition to B-ALL, and the impact of NBN variants on protein function and suggest that heterozygous NBN variant carriers may safely receive B-ALL therapy. These trials were registered at www.clinicaltrials.gov as #NCT01225874, NCT00075725, NCT00103285, NCI-T93-0101D, and NCT00137111.

1.
Pui
CH
,
Nichols
KE
,
Yang
JJ
.
Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
.
Nat Rev Clin Oncol
.
2019
;
16
(
4
):
227
-
240
.
2.
Churchman
ML
,
Qian
M
,
Te Kronnie
G
, et al
.
Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia
.
Cancer Cell
.
2018
;
33
(
5
):
937
-
948.e8
.
3.
Escherich
CS
,
Chen
W
,
Miyamoto
S
, et al
.
Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia
.
Blood Adv
.
2023
;
7
(
10
):
2177
-
2180
.
4.
Moriyama
T
,
Metzger
ML
,
Wu
G
, et al
.
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study
.
Lancet Oncol
.
2015
;
16
(
16
):
1659
-
1666
.
5.
Duployez
N
,
Jamrog
LA
,
Fregona
V
, et al
.
Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia
.
Blood
.
2021
;
137
(
10
):
1424
-
1428
.
6.
Li
C
,
Zhao
X
,
He
Y
, et al
.
The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia
.
Pharmacogenet Genomics
.
2022
;
32
(
2
):
43
-
50
.
7.
Qian
M
,
Cao
X
,
Devidas
M
, et al
.
TP53 germline variations influence the predisposition and prognosis of B-cell acute lymphoblastic leukemia in children
.
J Clin Oncol
.
2018
;
36
(
6
):
591
-
599
.
8.
Varon
R
,
Demuth
I
,
Chrzanowska
KH
. Nijmegen Breakage Syndrome. In:
Adam
MP
,
Feldman
J
,
Mirzaa
GM
, eds.
GeneReviews
.
Seattle, WA
:
University of Washington
;
1993-2024
.
9.
Lavoine
N
,
Colas
C
,
Muleris
M
, et al
.
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort
.
J Med Genet
.
2015
;
52
(
11
):
770
-
778
.
10.
Rosenberg
PS
,
Greene
MH
,
Alter
BP
.
Cancer incidence in persons with Fanconi anemia
.
Blood
.
2003
;
101
(
3
):
822
-
826
.
11.
Varon
R
,
Vissinga
C
,
Platzer
M
, et al
.
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome
.
Cell
.
1998
;
93
(
3
):
467
-
476
.
12.
Varon
R
,
Seemanova
E
,
Chrzanowska
K
, et al
.
Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations
.
Eur J Hum Genet
.
2000
;
8
(
11
):
900
-
902
.
13.
Kobayashi
J
,
Tauchi
H
,
Sakamoto
S
, et al
.
NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain
.
Curr Biol
.
2002
;
12
(
21
):
1846
-
1851
.
14.
Lukas
C
,
Melander
F
,
Stucki
M
, et al
.
Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention
.
EMBO J
.
2004
;
23
(
13
):
2674
-
2683
.
15.
You
Z
,
Chahwan
C
,
Bailis
J
,
Hunter
T
,
Russell
P
.
ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1
.
Mol Cell Biol
.
2005
;
25
(
13
):
5363
-
5379
.
16.
Stracker
TH
,
Morales
M
,
Couto
SS
,
Hussein
H
,
Petrini
JH
.
The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex
.
Nature
.
2007
;
447
(
7141
):
218
-
221
.
17.
Weemaes
CM
,
Hustinx
TW
,
Scheres
JM
,
van Munster
PJ
,
Bakkeren
JA
,
Taalman
RD
.
A new chromosomal instability disorder: the Nijmegen breakage syndrome
.
Acta Paediatr Scand
.
1981
;
70
(
4
):
557
-
564
.
18.
Sharapova
SO
,
Pashchenko
OE
,
Bondarenko
AV
, et al
.
Geographical distribution, incidence, malignancies, and outcome of 136 Eastern Slavic patients with Nijmegen breakage syndrome and NBN founder variant c.657_661del5
.
Front Immunol
.
2020
;
11
:
602482
.
19.
Wolska-Kusnierz
B
,
Pastorczak
A
,
Fendler
W
, et al
.
Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome
.
Clin Cancer Res
.
2021
;
27
(
2
):
575
-
584
.
20.
Seemanova
E
,
Jarolim
P
,
Seeman
P
, et al
.
Cancer risk of heterozygotes with the NBN founder mutation
.
J Natl Cancer Inst
.
2007
;
99
(
24
):
1875
-
1880
.
21.
Belhadj
S
,
Khurram
A
,
Bandlamudi
C
, et al
.
NBN pathogenic germline variants are associated with pan-cancer susceptibility and in vitro DNA damage response defects
.
Clin Cancer Res
.
2023
;
29
(
2
):
422
-
431
.
22.
Gao
P
,
Ma
N
,
Li
M
,
Tian
QB
,
Liu
DW
.
Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies
.
Mutagenesis
.
2013
;
28
(
6
):
683
-
697
.
23.
di Masi
A
,
Antoccia
A
.
NBS1 heterozygosity and cancer risk
.
Curr Genomics
.
2008
;
9
(
4
):
275
-
281
.
24.
Chrzanowska
KH
,
Piekutowska-Abramczuk
D
,
Popowska
E
, et al
.
Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies
.
Int J Cancer
.
2006
;
118
(
5
):
1269
-
1274
.
25.
Varon
R
,
Reis
A
,
Henze
G
,
von Einsiedel
HG
,
Sperling
K
,
Seeger
K
.
Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL)
.
Cancer Res
.
2001
;
61
(
9
):
3570
-
3572
.
26.
Mosor
M
,
Ziolkowska
I
,
Pernak-Schwarz
M
,
Januszkiewicz-Lewandowska
D
,
Nowak
J
.
Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia
.
Leukemia
.
2006
;
20
(
8
):
1454
-
1456
.
27.
Mosor
M
,
Ziolkowska-Suchanek
I
,
Nowicka
K
,
Dzikiewicz-Krawczyk
A
,
Januszkiewicz-Lewandowska
D
,
Nowak
J
.
Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia
.
BMC Cancer
.
2013
;
13
:
457
.
28.
Rahman
S
,
Canny
MD
,
Buschmann
TA
,
Latham
MP
.
A survey of reported disease-related mutations in the MRE11-RAD50-NBS1 complex
.
Cells
.
2020
;
9
(
7
):
1678
.
29.
de Smith
AJ
,
Lavoie
G
,
Walsh
KM
, et al
.
Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children
.
Genes Chromosomes Cancer
.
2019
;
58
(
10
):
723
-
730
.
30.
Winer
P
,
Muskens
IS
,
Walsh
KM
, et al
.
Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia
.
Blood Adv
.
2020
;
4
(
4
):
672
-
675
.
31.
Borowitz
MJ
,
Devidas
M
,
Hunger
SP
, et al
.
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
.
Blood
.
2008
;
111
(
12
):
5477
-
5485
.
32.
Larsen
EC
,
Devidas
M
,
Chen
S
, et al
.
Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from Children's Oncology Group Study AALL0232
.
J Clin Oncol
.
2016
;
34
(
20
):
2380
-
2388
.
33.
Maloney
KW
,
Devidas
M
,
Wang
C
, et al
.
Outcome in children with standard-risk B-cell acute lymphoblastic leukemia: results of Children's Oncology Group Trial AALL0331
.
J Clin Oncol
.
2020
;
38
(
6
):
602
-
612
.
34.
Pui
CH
,
Campana
D
,
Pei
D
, et al
.
Treating childhood acute lymphoblastic leukemia without cranial irradiation
.
N Engl J Med
.
2009
;
360
(
26
):
2730
-
2741
.
35.
Pui
CH
,
Pei
D
,
Sandlund
JT
, et al
.
Long-term results of St Jude total therapy studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia
.
Leukemia
.
2010
;
24
(
2
):
371
-
382
.
36.
Li
Y
,
Yang
W
,
Devidas
M
, et al
.
Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia
.
J Clin Invest
.
2021
;
131
(
17
):
e147898
.
37.
Matreyek
KA
,
Starita
LM
,
Stephany
JJ
, et al
.
Multiplex assessment of protein variant abundance by massively parallel sequencing
.
Nat Genet
.
2018
;
50
(
6
):
874
-
882
.
38.
Matreyek
KA
,
Stephany
JJ
,
Chiasson
MA
,
Hasle
N
,
Fowler
DM
.
An improved platform for functional assessment of large protein libraries in mammalian cells
.
Nucleic Acids Res
.
2020
;
48
(
1
):
e1
.
39.
Suiter
CC
,
Moriyama
T
,
Matreyek
KA
, et al
.
Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity
.
Proc Natl Acad Sci U S A
.
2020
;
117
(
10
):
5394
-
5401
.
40.
Chen
W
,
Wang
S
,
Tithi
SS
,
Ellison
DW
,
Schaid
DJ
,
Wu
G
.
A rare variant analysis framework using public genotype summary counts to prioritize disease-predisposition genes
.
Nat Commun
.
2022
;
13
(
1
):
2592
.
41.
Karczewski
KJ
,
Francioli
LC
,
Tiao
G
, et al
.
The mutational constraint spectrum quantified from variation in 141,456 humans
.
Nature
.
2020
;
581
(
7809
):
434
-
443
.
42.
Kircher
M
,
Witten
DM
,
Jain
P
,
O'Roak
BJ
,
Cooper
GM
,
Shendure
J
.
A general framework for estimating the relative pathogenicity of human genetic variants
.
Nat Genet
.
2014
;
46
(
3
):
310
-
315
.
43.
Kruger
L
,
Demuth
I
,
Neitzel
H
, et al
.
Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein
.
Carcinogenesis
.
2007
;
28
(
1
):
107
-
111
.
44.
Kraakman-van der Zwet
M
,
Overkamp
WJ
,
Friedl
AA
, et al
.
Immortalization and characterization of Nijmegen breakage syndrome fibroblasts
.
Mutat Res
.
1999
;
434
(
1
):
17
-
27
.
45.
Cerosaletti
KM
,
Desai-Mehta
A
,
Yeo
TC
,
Kraakman-Van Der Zwet
M
,
Zdzienicka
MZ
,
Concannon
P
.
Retroviral expression of the NBS1 gene in cultured Nijmegen breakage syndrome cells restores normal radiation sensitivity and nuclear focus formation
.
Mutagenesis
.
2000
;
15
(
3
):
281
-
286
.
46.
Jumper
J
,
Evans
R
,
Pritzel
A
, et al
.
Highly accurate protein structure prediction with AlphaFold
.
Nature
.
2021
;
596
(
7873
):
583
-
589
.
47.
Maurer
MH
,
Hoffmann
K
,
Sperling
K
,
Varon
R
.
High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany
.
J Appl Genet
.
2010
;
51
(
2
):
211
-
214
.
48.
Pastorczak
A
,
Attarbaschi
A
,
Bomken
S
, et al
.
Consensus recommendations for the clinical management of hematological malignancies in patients with DNA double stranded break disorders
.
Cancers (Basel)
.
2022
;
14
(
8
):
2000
.
49.
Dumon-Jones
V
,
Frappart
PO
,
Tong
WM
, et al
.
Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis
.
Cancer Res
.
2003
;
63
(
21
):
7263
-
7269
.
50.
Tanzanella
C
,
Antoccia
A
,
Spadoni
E
, et al
.
Chromosome instability and nibrin protein variants in NBS heterozygotes
.
Eur J Hum Genet
.
2003
;
11
(
4
):
297
-
303
.
51.
Maser
RS
,
Zinkel
R
,
Petrini
JH
.
An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele
.
Nat Genet
.
2001
;
27
(
4
):
417
-
421
.
52.
di Masi
A
,
Viganotti
M
,
Polticelli
F
,
Ascenzi
P
,
Tanzarella
C
,
Antoccia
A
.
The R215W mutation in NBS1 impairs gamma-H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients
.
Biochem Biophys Res Commun
.
2008
;
369
(
3
):
835
-
840
.
53.
Schroder-Heurich
B
,
Bogdanova
N
,
Wieland
B
, et al
.
Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line
.
BMC Cancer
.
2014
;
14
:
434
.
54.
Williams
RS
,
Dodson
GE
,
Limbo
O
, et al
.
Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair
.
Cell
.
2009
;
139
(
1
):
87
-
99
.
55.
Chen
Y
,
Sun
J
,
Ju
Z
,
Wang
ZQ
,
Li
T
.
Nbs1-mediated DNA damage repair pathway regulates haematopoietic stem cell development and embryonic haematopoiesis
.
Cell Prolif
.
2021
;
54
(
3
):
e12972
.
56.
Kim
JH
,
Penson
AV
,
Taylor
BS
,
Petrini
JHJ
.
Nbn-Mre11 interaction is required for tumor suppression and genomic integrity
.
Proc Natl Acad Sci U S A
.
2019
;
116
(
30
):
15178
-
15183
.
57.
Piatosa
B
,
van der Burg
M
,
Siewiera
K
, et al
.
The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation
.
Cytometry A
.
2012
;
81
(
10
):
835
-
842
.
58.
van der Burg
M
,
Pac
M
,
Berkowska
MA
, et al
.
Loss of juxtaposition of RAG-induced immunoglobulin DNA ends is implicated in the precursor B-cell differentiation defect in NBS patients
.
Blood
.
2010
;
115
(
23
):
4770
-
4777
.
59.
Filipiuk
A
,
Kozakiewicz
A
,
Kosmider
K
,
Lejman
M
,
Zawitkowska
J
.
Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies
.
Ann Agric Environ Med
.
2022
;
29
(
2
):
207
-
214
.
60.
Holmfeldt
L
,
Wei
L
,
Diaz-Flores
E
, et al
.
The genomic landscape of hypodiploid acute lymphoblastic leukemia
.
Nat Genet
.
2013
;
45
(
3
):
242
-
252
.
You do not currently have access to this content.
Sign in via your Institution